Strong evidence for colchicine in patients with chronic coronary disease - PACE-CME

Strong evidence for colchicine in patients with chronic coronary disease

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
ESC 2020
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
- Prof. Renato D. Lopes, MD, PhD
Updates in the 2020 AF guidelines
Updates in the 2020 AF guidelines
ESC 2020
Updates in the 2020 AF guidelines
- Isabelle van Gelder, MD, PhD
BP lowering should be considered irrespective of prior CVD or baseline SBP
BP lowering should be considered irrespective of prior CVD or baseline SBP
ESC 2020
BP lowering should be considered irrespective of prior CVD or baseline SBP
- Kazem Rahimi, MD
Colchicine reduces primary outcome in chronic coronary disease
Colchicine reduces primary outcome in chronic coronary disease
ESC 2020
Colchicine reduces primary outcome in chronic coronary disease
- Mark Nidorf, MD